跳至主要内容
临床试验/JPRN-jRCT2031200204
JPRN-jRCT2031200204招募中未知

Survey of proper use and occurrence of hyperkalemia after administration of MINNEBRO tablets in patients with hypertension-MID-NET Cohort Study

Matsuoka Yomei0 个研究点目标入组 3,100 人开始时间: 2020年11月27日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
3,100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Prescription of MINNEBRO tablets has commenced during the enrollment period (May 13, 2019 to May 31, 2023).
  • -The diagnosis of hypertension exists between the first prescription day and 30 days before the first prescription day of this drug during the enrollment period.
  • -The date of the earliest medical record after the start date of the data period is 180 days or more prior to the date of the first prescription of this drug.

排除标准

  • 未提供

研究者

发起方
Matsuoka Yomei

相似试验